Anti-neuroinflammatory effects of the calcium channel blocker nicardipine on microglial cells: Implications for neuroprotection

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Huang, Bor Ren ^a,b,c   Chang, Pei Chun ^d   Yeh, Wei Lan ^e   Lee, Chih Hao ^f   Tsai, Cheng Fang ^d   Lin, Chingju ^g   Lin, Hsiao Yun ^h   Liu, Yu Shu ^a   Wu, Caren Yu Ju ^a   Ko, Pei Ying ^a   Huang, Shiang Suo ⁱ   Hsu, Horng Chaung ^a,j   Lu, Dah Yuu ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b Buddhist General Tzu Chi Hospital   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^f HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

ⁱ CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^j CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CYCLOOXYGENASE 2; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NICARDIPINE; NITRIC OXIDE; PEPTIDOGLYCAN; CALCIUM CHANNEL BLOCKING AGENT; CYTOKINE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL MEMBRANE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME INHIBITION; GRAM POSITIVE BACTERIUM; IN VIVO STUDY; MICROGLIA; MOUSE; MURINAE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN FUNCTION; ANIMAL; BLOOD PRESSURE; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; INFLAMMATION; MICE; MICROGLIA; NEUROPROTECTIVE AGENTS; NICARDIPINE; SIGNAL TRANSDUCTION;

EID: 84898006807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091167     Document Type: Article

References (76)

1. Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173: 3916-3924. (Pubitemid 39280755)
2. Czeh M, Gressens P, Kaindl AM (2011) The yin and yang of microglia. Dev Neurosci 33: 199-209.
3. Wee Yong V (2010) Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 16: 408-420.
4. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, et al. (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9: 268-275. (Pubitemid 43164551)
5. Koizumi S, Ohsawa K, Inoue K, Kohsaka S (2013) Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors. Glia 61: 47-54.
6. Leung YM (2011) P2X7 receptor as a double-edged sword: Neurotrophic and neurotoxic effects. BioMedicine 1: 16-20.
7. Guillot-Sestier MV, Town T (2013) Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets 12: 593-607.
8. Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, et al. (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum Brain Mapp 32: 258-270.
9. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8: 57-69. (Pubitemid 46011999)
10. Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 117: 971-979.
11. Patel AR, Ritzel R, McCullough LD, Liu F (2013) Microglia and ischemic stroke: a double-edged sword. Int J Physiol Pathophysiol Pharmacol 5: 73-90.
12. Lin C, Wu CJ, Wei IH, Tsai MH, Chang NW, et al. (2013) Chronic treadmill running protects hippocampal neurons from hypobaric hypoxia-induced apoptosis in rats. Neuroscience 231: 216-224.
13. Loihl AK, Murphy S (1998) Expression of nitric oxide synthase-2 in glia associated with CNS pathology. Prog Brain Res 118: 253-267. (Pubitemid 28530672)
14. Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21: 6480-6491. (Pubitemid 32781092)
15. Beckman JS, Chen J, Crow JP, Ye YZ (1994) Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res 103: 371-380.
16. Chao CC, Hu S, Peterson PK (1995) Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 58: 65-70.
17. Wang JY, Shum AY, Ho YJ, Wang JY (2003) Oxidative neurotoxicity in rat cerebral cortex neurons: synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J Neurosci Res 72: 508-519. (Pubitemid 36523425)
18. Liang X, Wu L, Wang Q, Hand T, Bilak M, et al. (2007) Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci 33: 94-99. (Pubitemid 47574964)
19. Yermakova A, O'Banion MK (2000) Cyclooxygenases in the central nervous system: implications for treatment of neurological disorders. Curr Pharm Des 6: 1755-1776.
20. Cho S, Park EM, Zhou P, Frys K, Ross ME, et al. (2005) Obligatory role of inducible nitric oxide synthase in ischemic preconditioning. J Cereb Blood Flow Metab 25: 493-501.
21. Knott C, Stern G, Wilkin GP (2000) Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16: 724-739. (Pubitemid 32062060)
22. Rasmuson S, Nasman B, Olsson T (2011) Increased serum levels of dehydroepiandrosterone (DHEA) and interleukin-6 (IL-6) in women with mild to moderate Alzheimer's disease. Int Psychogeriatr: 1-7.
23. Uslu S, Akarkarasu ZE, Ozbabalik D, Ozkan S, Colak O, et al. (2012) Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia. Neurochem Res 37: 1554-1559.
24. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, et al. (2002) Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22: 7004-7014.
25. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP (1994) A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 80: 788-796. (Pubitemid 24129672)
26. Narotam PK, Puri V, Roberts JM, Taylon C, Vora Y, et al. (2008) Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation. J Neurosurg 109: 1065-1074.
27. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, et al. (2001) Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 57: 18-24. (Pubitemid 32634845)
28. Kim SY, Kim SM, Park MS, Kim HK, Park KS, et al. (2012) Effectiveness of nicardipine for blood pressure control in patients with subarachnoid hemorrhage. J Cerebrovasc Endovasc Neurosurg 14: 84-89.
29. Qureshi A, Palesch Y, Investigators AI (2012) Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial. Journal of Vascular and Interventional Neurology 5: 6-9.
30. Qureshi AI, Palesch YY (2011) Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocritical Care 15: 559-576.
31. Sato S, Yamamoto H, Qureshi AI, Palesch YY, Toyoda K, et al. (2012) [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network]. Rinsho Shinkeigaku Clinical Neurology 52: 642-650.
32. Amenta F, Strocchi P, Sabbatini M (1996) Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine. Journal of Hypertension Supplement 14: S29-35. (Pubitemid 27049511)
33. Amenta F, Tomassoni D (2004) Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clinical and Experimental Hypertension 26: 351-361. (Pubitemid 38691116)
34. Amenta F, Tomassoni D, Traini E, Mignini F, Veglio F (2008) Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile. Clinical and Experimental Hypertension 30: 808-826.
35. Mikami C, Suzuki M, Tsuiki K, Ogawa A (2001) Effect of nicardipine and magnesiumon cerebral infarction - brain surface perfusion technique. Cerebrovasc Dis 11: 44-50. (Pubitemid 32098427)
36. Koizumi S, Saito Y, Nakazawa K, Nakajima K, Sawada JI, et al. (2002) Spatial and temporal aspects of Ca2+ signaling mediated by P2Y receptors in cultured rat hippocampal astrocytes. Life Sciences 72: 431-442. (Pubitemid 35447766)
37. Komagiri Y, Nakamura K, Kubokawa M (2011) A nicardipine-sensitive Ca2+ entry contributes to the hypotonicity-induced increase in [Ca2+]i of principal cells in rat cortical collecting duct. Cell Calcium 49: 35-42.
38. Liu Y, Lo YC, Qian L, Crews FT, Wilson B, et al. (2011) Verapamil protects dopaminergic neuron damage through a novel anti-inflammatory mechanism by inhibition of microglial activation. Neuropharmacology 60: 373-380.
39. Sanz JM, Chiozzi P, Colaianna M, Zotti M, Ferrari D, et al. (2012) Nimodipine inhibits IL-1beta release stimulated by amyloid beta from microglia. Br J Pharmacol 167: 1702-1711.
40. McGrath JC, Drummond GB, McLachlan EM, Kilkenny C, Wainwright CL (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
41. Saijonmaa O, Metsarinne K, Fyhrquist F (1997) Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture. Blood Press 6: 24-28. (Pubitemid 27072775)
42. Gasior M, Kaminski R, Brudniak T, Kleinrok Z, Czuczwar SJ (1996) Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice. J Neural Transm 103: 819-831. (Pubitemid 26383658)
43. Lin HY, Huang BR, Yeh WL, Lee CH, Huang SS, et al. (2014) Antineuroinflammatory effects of lycopene via activation of adenosine monophosphate-activated protein kinase-alpha1/heme oxygenase-1 pathways. Neurobiol Aging 35: 191-202.
44. Tsai CF, Yeh WL, Huang SM, Tan TW, Lu DY (2012) Wogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells. Int J Mol Sci 13: 9877-9892.
45. Huang SM, Cheung CW, Chang CS, Tang CH, Liu JF, et al. (2011) Phloroglucinol derivative MCPP induces cell apoptosis in human colon cancer. J Cell Biochem 112: 643-652.
46. Henry CJ, Huang Y, Wynne AM, Godbout JP (2009) Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines. Brain Behav Immun 23: 309-317.
47. Chen JH, Huang SM, Tan TW, Lin HY, Chen PY, et al. (2012) Berberine induces heme oxygenase-1 up-regulation through phosphatidylinositol 3-kinase/AKT and NF-E2-related factor-2 signaling pathway in astrocytes. Int Immunopharmacol 12: 94-100.
48. Chen JH, Huang SM, Chen CC, Tsai CF, Yeh WL, et al. (2011) Ghrelin induces cell migration through GHS-R, CaMKII, AMPK, and NF-kappaB signaling pathway in glioma cells. J Cell Biochem 112: 2931-2941.
49. Lu DY, Leung YM, Cheung CW, Chen YR, Wong KL (2010) Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloprotei-nase- 13 expression in glioma cells. Biochem Pharmacol 80: 1201-1209.
50. Lu DY, Yeh WL, Huang SM, Tang CH, Lin HY, et al. (2012) Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells. Neuro Oncol 14: 1367-1378.
51. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, et al. (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481: 506-510.
52. Huang BR, Tsai CF, Lin HY, Tseng WP, Huang SS, et al. (2013) Interaction of inflammatory and anti-inflammatory responses in microglia by Staphylococcus aureus-derived lipoteichoic acid. Toxicol Appl Pharmacol 269: 43-50.
53. Leung YM, Wong KL, Chen SW, Lu DY, Kuo CS, et al. (2013) Downregulation of voltage-gated Ca2+ channels in Ca2+ store-depleted rat insulinoma RINm5F cells. BioMedicine 3: 130-139.
54. Lin HY, Tang CH, Chen JH, Chuang JY, Huang SM, et al. (2011) Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun, and AP-1 pathways in microglia. J Cell Physiol 226: 1573-1582.
55. Lin HY, Tang CH, Chen YH, Wei IH, Chen JH, et al. (2010) Peptidoglycan enhances proinflammatory cytokine expression through the TLR2 receptor, MyD88, phosphatidylinositol 3-kinase/AKT and NF-kappaB pathways in BV-2 microglia. Int Immunopharmacol 10: 883-891.
56. Lu DY, Tang CH, Yeh WL, Wong KL, Lin CP, et al. (2009) SDF-1alpha upregulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol 613: 146-154.
57. Lu DY, Tang CH, Liou HC, Teng CM, Jeng KC, et al. (2007) YC-1 attenuates LPS-induced proinflammatory responses and activation of nuclear factor-kappaB in microglia. Br J Pharmacol 151: 396-405. (Pubitemid 46842665)
58. Lu DY, Liou HC, Tang CH, Fu WM (2006) Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72: 992-1000. (Pubitemid 44374459)
59. Lu DY, Tang CH, Chen YH, Wei IH (2010) Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J Cell Biochem 110: 697-705.
60. Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, et al. (2007) Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-associated vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol 28: 844-848. (Pubitemid 46776059)
61. Gianino JW, Afuwape LO (2012) Evidence-based guidelines for the management of traumatic brain injury. Missouri Medicine 109: 384-387.
62. Qureshi AI, Harris-Lane P, Kirmani JF, Ahmed S, Jacob M, et al. (2006) Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Critical Care Medicine 34: 1975-1980. (Pubitemid 43982476)
63. Degoute CS (2007) Controlled hypotension: a guide to drug choice. Drugs 67: 1053-1076.
64. Babu CS, Ramanathan M (2011) Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. Int J Dev Neurosci 29: 93-105.
65. Matsui T, Takeuchi M, Yamagishi S (2010) Nifedipine, a calcium channel blocker, inhibits inflammatory and fibrogenic gene expressions in advanced glycation end product (AGE)-exposed fibroblasts via mineralocorticoid receptor antagonistic activity. Biochem Biophys Res Commun 396: 566-570.
66. Casamassima F, Hay AC, Benedetti A, Lattanzi L, Cassano GB, et al. (2010) L-type calcium channels and psychiatric disorders: A brief review. Am J Med Genet B Neuropsychiatr Genet 153B: 1373-1390.
67. Triggle DJ (2007) Calcium channel antagonists: clinical uses-past, present and future. Biochem Pharmacol 74: 1-9.
68. Hashioka S, Klegeris A, McGeer PL (2012) Inhibition of human astrocyte and microglia neurotoxicity by calcium channel blockers. Neuropharmacology 63: 685-691.
69. Michelucci A, Heurtaux T, Grandbarbe L, Morga E, Heuschling P (2009) Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta. J Neuroimmunol 210: 3-12.
70. Zhang XL, Zheng SL, Dong FR, Wang ZM (2012) Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia. J Int Med Res 40: 1036-1045.
71. Su PY, Liu SJ, Chen YH, Wu SS, Chen YL, et al. (2013) Increased IL-8 and IL-1β in the bile of acute cholecystitis patients. BioMedicine 3: 181-185.
72. Maa MC (2013) Infectious diseases: A never-ending threat. BioMedicine 3: 1.
73. Schut ES, de Gans J, van de Beek D (2008) Community-acquired bacterial meningitis in adults. Pract Neurol 8: 8-23. (Pubitemid 351234349)
74. Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36: 407-477.
75. Hayashi M, Yamaji Y, Nakazato Y, Saruta T (2000) The effects of calcium channel blockers on nuclear factor kappa B activation in the mesangium cells. Hypertens Res 23: 521-525.
76. Lu DY, Leung YM, Su KP (2013) Interferon-alpha induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellularmechanism of IFN-alpha-induced depression. Int J Neuropsychopharmacol 16: 433-444.